Polyphenol-Based Therapeutics in Periodontal Health

Polyphenols are a diverse class of plant-derived secondary metabolites renowned for their antioxidant, anti-inflammatory and antimicrobial activities. In the context of periodontal health, these compounds target both microbial biofilms and the host inflammatory response, thereby addressing key drivers of periodontitis. By disrupting the adhesion and growth of periodontopathogenic bacteria, polyphenols limit biofilm maturation and virulence factor production. Concurrently, they scavenge reactive oxygen species and modulate signal transduction pathways, preserving epithelial barrier integrity and attenuating cytokine release. Animal and preliminary clinical studies report reductions in alveolar bone loss and improvements in clinical indices of gingival inflammation. Ongoing efforts explore novel delivery systems—such as mucoadhesive gels or nanoparticles—to enhance local bioavailability and sustained release in the subgingival milieu. Collectively, these developments underscore the potential of polyphenol-based interventions as adjuncts to conventional periodontal therapies.

Research from Nature Portfolio

Recent studies have demonstrated that tea-derived polyphenols, notably epigallocatechin-3-gallate (EGCG) and theaflavins, exert potent actions against Fusobacterium nucleatum, a keystone species in subgingival biofilms. These compounds compromise bacterial cell membranes, chelate essential metal ions and prevent biofilm formation without affecting planktonic viability. In pre-formed biofilms, treatment leads to time-dependent reductions in bacterial viability and diminished adherence to epithelial matrices. In parallel, investigations into macrophage and monocyte models reveal that tea polyphenols inhibit activation of the nuclear factor-κB (NF-κB) pathway in response to F. nucleatum challenge. This suppression translates into decreased secretion of pro-inflammatory cytokines (including IL-1β, IL-6, TNF-α and CXCL8), lower matrix metalloproteinase release and reduced shedding of triggering receptor expressed on myeloid cells-1, reinforcing their dual antibacterial and host-modulatory roles.

Polyphenol-Based Therapeutics in Periodontal Health publication trend

The graph below shows the total number of articles in polyphenol-based therapeutics in periodontal health across all publications each year (not limited to Nature Index journals).

Technical terms

Polyphenols: Plant-derived compounds with multiple phenolic rings; exhibit antioxidant, anti-inflammatory and antimicrobial properties.

Biofilm: Structured community of microorganisms attached to a surface and embedded in an extracellular matrix.

Reactive oxygen species (ROS): Chemically reactive molecules containing oxygen that can damage cells and tissues when in excess.

NF-κB (nuclear factor-κB): A transcription factor central to the regulation of inflammatory gene expression.

Matrix metalloproteinases (MMPs): Enzymes that degrade extracellular matrix components; implicated in tissue destruction.

Periodontopathogenic bacteria: Microorganisms associated with periodontal disease, such as Porphyromonas gingivalis and Fusobacterium nucleatum.

Epigallocatechin-3-gallate (EGCG): A predominant catechin in green tea with pronounced bioactive effects.

Theaflavins: Polyphenolic compounds formed during black tea fermentation; possess antimicrobial and anti-inflammatory activity.

Host modulation therapy: Treatment approach aimed at regulating the host immune and inflammatory response rather than directly targeting pathogens.

References

1. Polyphenols in Oral Health: Homeostasis Maintenance, Disease Prevention, and Therapeutic Applications. Nutrients (2023).
2. Tea polyphenols inhibit the growth and virulence properties of Fusobacterium nucleatum. Scientific Reports (2017).
3. Tea polyphenols inhibit the activation of NF-κB and the secretion of cytokines and matrix metalloproteinases by macrophages stimulated with Fusobacterium nucleatum. Scientific Reports (2016).
4. Prunin Laurate Derived from Natural Substances Shows Antibacterial Activity against the Periodontal Pathogen Porphyromonas gingivalis. Foods (2024).
5. Effect of Hesperidin on Barrier Function and Reactive Oxygen Species Production in an Oral Epithelial Cell Model, and on Secretion of Macrophage-Derived Inflammatory Mediators during Porphyromonas gingivalis Infection. International Journal of Molecular Sciences (2023).